News

SpringWorks Therapeutics announced the European Commission has granted Orphan Drug Designation for nirogacestat, an oral, selective, small molecule, gamma-secretase inhibitor, for the…
Read More...

Blade Therapeutics, a biopharmaceutical company advancing novel anti-fibrotic therapies, announced the acquisition of ATXCo, Inc., including its core asset, PAT-409, a Phase I ready…
Read More...

Achillion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for danicopan (ACH-4471) for treatment in combination…
Read More...

IMMUNOPRECISE ANTIBODIES, an industry leader in the discovery of novel, therapeutic antibodies, announces that Talem Therapeutics, its wholly-owned subsidiary, has entered into an LOI…
Read More...

Zealand Pharma A/S announces positive results in the pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia in diabetes. Dasiglucagon is a potential first-in-class soluble…
Read More...

Aldeyra Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ADX-2191 for the prevention of proliferative vitreoretinopathy…
Read More...

Pfizer Inc. and Flatiron Health announced an expanded strategic collaboration to further integrate and increase the use of real-world data in Pfizer’s development of innovative targeted…
Read More...

The U.S. Food and Drug Administration announced the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in…
Read More...

Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five…
Read More...

NeuCyte, Inc., an innovative biotech company focused on developing novel treatments for neurological disorders, announced that it has entered into an exclusive license agreement with…
Read More...

Catalent and Minerva Neurosciences announced that they have entered into a long-term commercial supply agreement for roluperidone (MIN-101), an investigational compound under…
Read More...

PCI Pharma Services (PCI) has officially opened its newly expanded Clinical Center of Excellence in Rockford, IL. Rockford City Council Director of Community and Economic…
Read More...

Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the commercial…
Read More...

I-Mab Biopharma, a China and U.S.-based clinical stage biopharmaceutical company exclusively focusing on the discovery and development of potential first-in-class and best-in-class…
Read More...

Clovis Oncology has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted…
Read More...

Proteon Therapeutics and ArTara Therapeutics announced that they have entered into a definitive agreement in which a wholly-owned subsidiary of Proteon will merge with ArTara in an…
Read More...

AstraZeneca announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in the European…
Read More...

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet…
Read More...

Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.…
Read More...

Cryoport, Inc. announced the launch of its Advanced Therapy Shipper product line for the regenerative medicine market. The Advanced Therapy Shipper guarantees each shipper has been used…
Read More...